Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion
2007
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer’s Disease
2009
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Inflammation and Alzheimer's disease
2000 Standout
An early complement-dependent and TLR-4–independent phase in the pathogenesis of ethanol-induced liver injury in mice #
2008
Complement and its role in innate and adaptive immune responses
2009 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
2014
Intracerebral haemorrhage
2009 Standout
Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy
2005
The spectrum of neuromyelitis optica
2007 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
2005 Standout
The role of complement in disorders of the nervous system
1997
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Myasthenia Gravis Thymus
2007
Spontaneous Classical Pathway Activation and Deficiency of Membrane Regulators Render Human Neurons Susceptible to Complement Lysis
2000
Descending control of pain
2002 Standout
The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer’s disease
2000
The N-formyl peptide receptors and the anaphylatoxin C5a receptors: An overview
2007
Complement in neuroprotection and neurodegeneration
2010
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
High Levels of Complement C3a Receptor in the Glomeruli in Lupus Nephritis
2007
Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor
1999
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Molecular aspects of inflammatory and immune responses in Alzheimer's disease
1996
Differential Contributions of C3, C5, and Decay-Accelerating Factor to Ethanol-Induced Fatty Liver in Mice
2007
New Horizons for Primary Intracerebral Hemorrhage Treatment: Experience From Preclinical Studies
2005
Phagocyte Chemoattractant Receptors
1997
Complement: a novel factor in basal and ischemia‐induced neurogenesis
2006
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Expression of the anaphylatoxin C5a receptor in non-myeloid cells
1999
Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
1999
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Interleukin-6 expression and regulation in astrocytes
1999
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells
1998
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Mechanisms of brain injury after intracerebral haemorrhage
2005 Standout
Yin and Yang: complement activation and regulation in Alzheimer’s disease
2003
The inflammatory response in myocardial infarction
2002 Standout
Complement factors and their receptors
1997
Complement resistance of tumor cells: basal and induced mechanisms
1999
HIV-infection of the central nervous system: the tightrope walk of innate immunity
2004
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Elements of cerebral microvascular ischaemia
2001
C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation
2008
Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: Insights from the study of fish complement
2005
Nrf2 signaling modulates cigarette smoke-induced complement activation in retinal pigmented epithelial cells
2014
Temporal pattern of C1q deposition after transient focal cerebral ischemia
2006
Photodynamic therapy and anti-tumour immunity
2006 Standout
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
The immunology of stroke: from mechanisms to translation
2011 Standout
Alzheimer's disease
2016 Standout
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
2006 Standout
Role of C5a???C5aR Interaction in Sepsis
2003
Expression of complement in the brain: role in health and disease
1996
Engineering patient-specific cancer immunotherapies
2019
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.
2006
Alzheimer's Disease
2010 Standout
Tripartite synapses: glia, the unacknowledged partner
1999 Standout
Antibody-mediated organ-allograft rejection
2005
Physiology and Pathophysiology of Complement: Progress and Trends
1995
Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia
1996
Complement components of the innate immune system in health and disease in the CNS
2000
Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats
2016
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
The complement‐derived anaphylatoxin C5a increases microglial GLT‐1 expression and glutamate uptake in a TNF‐α‐independent manner
2009
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Insight into nanoparticle cellular uptake and intracellular targeting
2014
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
2000 Standout
Anaphylatoxins
2007
Increased Complement Biosynthesis By Microglia and Complement Activation on Neurons in Huntington's Disease
1999
The role of the anaphylatoxins in health and disease
2009
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia
1995
The dark side of C5a in sepsis
2004
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Expression of complement messenger RNAs and proteins by human oligodendroglial cells
2003
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications
2014
ROLE OF C5A IN INFLAMMATORY RESPONSES
2005
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation
2003
ROLE OF COMPLEMENT IN HIV INFECTION
1997
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
2005 Standout
INFLAMMATION AND ALZHEIMERS DISEASE
2000
The Receptor for Complement Anaphylatoxin C3a Is Expressed by Myeloid Cells and Nonmyeloid Cells in Inflamed Human Central Nervous System: Analysis in Multiple Sclerosis and Bacterial Meningitis
1998
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
1998
Complement in multiple sclerosis: its role in disease and potential as a biomarker
2008
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue
2014
Glial Calcium: Homeostasis and Signaling Function
1998
Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a
2004 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Beyond lysis: how complement influences cell fate
2003
Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2
2008
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Dendritic Cell Function in Allostimulation Is Modulated by C5aR Signaling
2009
Functions of the complement components C3 and C5 during sepsis
2008
Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.
1997
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Physiology of Microglia
2011 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Complement-Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells
2009
Complement Gene Expression by Rabbit Heart
1998
Works of A. Ischenko being referenced
Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma
2015
C3A binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL‐8
2001
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
2001
Interleukin-1β and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes
2006
Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes
1997
Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma
2013
Expression of a Functional Anaphylatoxin C3a Receptor by Astrocytes
1998
Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors
2014
Complement component anaphylatoxins upregulate chemokine expression by human astrocytes
2003
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma
2015
Expression of Cytokines by Human Astrocytomas Following Stimulation by C3a and C5a Anaphylatoxins
1999
Characterization of a C1Q receptor on human glioma cell lines
1993
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells
2003
Expression of complement components of the alternative pathway by glioma cell lines
1992
Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells.
1993
IL-1 Receptor Antagonist-Mediated Therapeutic Effect in Murine Myasthenia Gravis Is Associated with Suppressed Serum Proinflammatory Cytokines, C3, and Anti-Acetylcholine Receptor IgG1
2005
Characterization of a complement C3a receptor (C3aR) on astrocytes
1994
Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes.
1995